AN2 Therapeutics, Inc. - Common Stock (NQ:ANTX)
1.250
-0.010
(-0.79%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 21, 2025
Add to My Watchlist
All News about AN2 Therapeutics, Inc. - Common Stock![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() Via Talk Markets
![]() ![]()
Increased R&D Activities Have Fueled Growth and Promise for Pancreatic Cancer Treatment
May 20, 2021
Topics
Death
Exposures
Death
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|